GSK Study Finds Voltaren Is Analgesic Of Choice For Elderly Germans
Executive Summary
As GSK's Voltaren celebrates its 20th anniversary, the OTC analgesic brand remains as popular as ever with elderly Germans, according to a new study by the firm.
You may also be interested in...
Winners In CHPA’s First OTC Marketing Awards Include Perrigo, J&J, GSK
CHPA awarded five grand prize winners from more than 40 consumer health companies entered in its first US OTC Marketing Awards. Perrigo won for “Best OTC Corporate Social Responsibility Campaign” and a J&J Tylenol campaign honoring caregivers was named “Best OTC Digital Campaign.”
Sweden Reverse-Switches Diclofenac Over Cardio Fears
Oral diclofenac will no longer be available without a prescription in Sweden after the national drug regulator judged that the potential adverse event risks were too high to justify continued OTC supply. Products from GSK and Mylan will be affected by the decision.
GSK Plans Further Divestments As Pfizer Brands Drive Up Q3 Sales
GSK is plotting further divestments into next year as it looks to focus its portfolio on key categories and raise funds to cover the costs of integrating Pfizer's Consumer Healthcare business. In the third quarter, GSK's sales advanced double-digits thanks to the inclusion of Pfizer megabrands like Advil and Centrum.